Inactive Instrument

Calendar Galena Biopharma Inc Nasdaq

Equities

US3632561086

End-of-day quote Nasdaq Other stock markets
- ^USD	-

01/05	SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level	CI
29/04	SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study	CI

Chart calendar Galena Biopharma Inc

86770bc23a7dbc0ef.EJ-rN_wDzcGW6SjLYQHmajC2f4YRQ-U0N2aX5YF5_5M.JO3oQqtptZ67v32dBkqsAlznBu9BcolmVCHdi9AxyvZj1OIEvVq48P-YEA~5fe48ffbdee8366a7248217091c870bc

Upcoming events on Galena Biopharma Inc

09/05/2024	Q1 2024 Earnings Release (Projected)
08/08/2024	Q2 2024 Earnings Release (Projected)
14/11/2024	Q3 2024 Earnings Release (Projected)
20/03/2025	Q4 2024 Earnings Release (Projected)

Past events on Galena Biopharma Inc

29/03/2024 01:35 am	Q4 2023 Earnings Release
26/03/2024 05:45 pm	Business Update Call
03/03/2024 04:30 pm	European School of Haematology Acute Leukaemias Conference - Abstract No:6192705
03/01/2024 07:00 pm	Business Update Call
23/11/2023 05:30 pm	Annual General Meeting
10/11/2023 02:34 am	Q3 2023 Earnings Release
05/11/2023	Global Meeting of the International Gynecologic Cancer Society
27/09/2023 06:40 pm	Cantor Global Healthcare Conference
11/08/2023 01:38 am	Q2 2023 Earnings Release
21/06/2023 07:00 pm	Maxim Group Virtual Healthcare Conference - Fireside Chat
20/06/2023 06:00 pm	Annual General Meeting
05/06/2023 06:30 pm	American Society of Clinical Oncology Conference - Abstract No : TPS7074
30/05/2023 05:30 pm	Business Update Call
12/05/2023 01:42 am	Q1 2023 Earnings Release
17/03/2023 01:41 am	Q4 2022 Earnings Release
31/01/2023 07:00 pm	Investor Meeting - Key Opinion Leader:Galinpepimut-S
13/12/2022	American Society of Hematology Meeting - Abstract #: 4263
12/12/2022	American Society of Hematology Meeting - Abstract #: 3477
08/12/2022 01:50 am	JMP Securities Hematology Oncology Summit
14/11/2022 07:00 pm	REGAL Phase 3 Clinical Trial Update Call

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	1,90 0,00 -	7,60 5,07 50%	1,00 1,00 0%	0,00 13,0 -	0,00
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-17,2 -15,7 -9.7%	-17,0 -16,9 -0.39%	-25,3 -24,3 -4.19%	-42,0 -37,7 -11.17%	-37,9 -30,3 -24.83%	-38,3
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-19,4 -14,4 -34.79%	-16,8 -17,2 2.64%	-20,9 -23,4 10.57%	-41,3 -39,6 -4.25%	-37,3 -25,8 -44.54%	-40,0
Net income Million USD	Released Forecast Spread	-28,0 -19,4 -43.97%	-16,8 -17,3 2.41%	-20,7 -21,1 2.04%	-41,3 -39,6 -4.25%	-37,3 -29,8 -25.2%	-40,0
EPS USD	Released Forecast Spread	-10,9 -9,71 -12.52%	-2,11 -1,83 -15.3%	-1,34 -1,34 -0.19%	-2,13 -2,10 -1.55%	-1,34 -1,10 -21.82%	-1,14
Announcement Date		13/03/20	23/03/21	31/03/22	16/03/23	28/03/24	-

Quarterly results

Fiscal Period	December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	1,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 13,0 -	0,00 13,0 -	0,00	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-11,6 -7,03 -65.32%	-6,74 -6,77 0.56%	-8,62 -7,39 -16.66%	-7,15 -8,00 10.71%	-9,45 -7,38 -27.96%	-11,3 -8,56 -31.86%	-8,84 -9,63 8.16%	-9,36 0,70 -1443.52%	-8,18 -0,64 -1168.4%	-10,0	-10,2	-10,4	-10,6
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-6,84 -6,95 1.72%	-16,7 -6,22 -169.41%	-8,41 -7,27 -15.7%	-7,02 -8,00 12.26%	-9,12 -7,17 -27.29%	-11,1 -8,51 -30.36%	-8,84 -9,56 7.49%	-9,27 0,73 -1368.15%	-8,14 3,37 -341.39%	-9,95	-9,96	-10,2	-10,5
Net income Million USD	Released Forecast Spread	-6,60 -6,95 5.12%	-16,7 -6,22 -169.41%	-8,41 -7,27 -15.7%	-7,02 -8,00 12.26%	-9,12 -7,17 -27.29%	-11,1 -8,51 -30.36%	-8,84 -9,56 7.49%	-9,27 0,73 -1368.15%	-8,14 3,37 -341.39%	-9,95	-9,96	-10,2	-10,5
EPS USD	Released Forecast Spread	-0,42 -0,40 -4.13%	-1,05 -0,38 -176.32%	-0,41 -0,39 -5.13%	-0,34 -0,39 12.07%	-0,43 -0,32 -34.38%	-0,47 -0,29 -62.07%	-0,31 -0,36 12.68%	-0,33 0,02 -1985.71%	-0,25 -0,03 -837.38%	-0,25	-0,20	-0,20	-0,19
Announcement Date		31/03/22	12/05/22	11/08/22	14/11/22	16/03/23	11/05/23	10/08/23	09/11/23	28/03/24	-	-	-	-

Upcoming sector events for Galena Biopharma Inc

06/05/2024	FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
06/05/2024	KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
06/05/2024	MERUS N.V.: Q1 2024 Earnings Release (Projected)
06/05/2024	VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024	INHIBRX, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024	BIONTECH SE: Q1 2024 Earnings Release
06/05/2024 04:30 pm	BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
07/05/2024 01:31 am	VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
07/05/2024	COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	LYELL IMMUNOPHARMA, INC.: Q1 2024 Earnings Release (Projected)

More events

Past sector events for Galena Biopharma Inc

03/05/2024 04:30 pm	GH RESEARCH PLC: Q1 2024 Earnings Release
03/05/2024 01:35 am	KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
03/05/2024 01:35 am	ZYMEWORKS INC.: Q1 2024 Earnings Release
03/05/2024 01:32 am	ARDELYX, INC.: Q1 2024 Earnings Release
03/05/2024 01:31 am	LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
03/05/2024 01:31 am	ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
03/05/2024 01:30 am	ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
02/05/2024 08:30 pm	GENMAB A/S: Q1 2024 Earnings Release
02/05/2024 04:30 pm	GERON CORPORATION: Q1 2024 Earnings Release
02/05/2024 04:30 pm	AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release